Pharmicell Co., Ltd. (KRX:005690)
12,480
-200 (-1.58%)
At close: Jul 25, 2025, 3:30 PM KST
Pharmicell Revenue
Pharmicell had revenue of 3.65B KRW in the quarter ending June 30, 2014, a decrease of -58.16%. This brings the company's revenue in the last twelve months to 23.94B, down -3.60% year-over-year. In the year 2013, Pharmicell had annual revenue of 33.41B with 200.63% growth.
Revenue (ttm)
23.94B
Revenue Growth
-3.60%
P/S Ratio
31.27
Revenue / Employee
n/a
Employees
n/a
Market Cap
748.85B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2013 | 33.41B | 22.29B | 200.63% |
Dec 31, 2012 | 11.11B | 829.38M | 8.07% |
Dec 31, 2011 | 10.28B | 3.07B | 42.47% |
Dec 31, 2010 | 7.22B | 28.94M | 0.40% |
Dec 31, 2009 | 7.19B | -1.14B | -13.68% |
Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
Peptron | 4.30B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |